S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Critical asset just had biggest fall on record (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$139.81
+2.97 (+2.17%)
(As of 03/1/2024 ET)
Today's Range
$137.11
$140.44
50-Day Range
$132.30
$140.89
52-Week Range
$111.83
$141.16
Volume
2.45 million shs
Average Volume
1.90 million shs
Market Capitalization
$7.79 billion
Assets Under Management
$7.74 billion
Dividend Yield
0.25%
Net Expense Ratio
0.44%
IBB stock logo

About iShares Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

IBB Stock Price History

IBB ETF News Headlines

IBB Mar 2024 141.000 call
IBB Mar 2024 120.000 put
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
IBB Mar 2024 139.000 call
IBB Mar 2024 133.000 put
IBB Mar 2024 129.000 call
IBB Mar 2024 136.500 call
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
IBB Mar 2024 124.000 call
See More Headlines
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
ICE Biotechnology Index (TR) (USD)
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
228

Fund Statistics

Assets Under Management
$7.74 billion
Average Daily Volume
$2.02 million
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
9,053
Put Options
4,877
Call Options
4,176
Short Interest
8,740,000 shs

Miscellaneous

Beta
0.73
Creation Unit
50,000
Creation Fee
$614.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.44%0.57%0.54%0.48%0.51%
Other Expenses0.00%0.40%0.55%0.33%0.58%
Total Expense0.44%0.72%0.70%0.57%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.20%-0.57%
Net Expense0.44%0.61%0.60%0.53%0.58%

iShares Biotechnology ETF (IBB) Holdings & Exposure

Key Executives

  • George G. C. Parker Ph.D.
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham
    President, Trustee
  • Jack Gee
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President

  • Bio & Compensation - 
  • Amy Schioldager
    Executive Vice President
  • Ira P. Shapiro
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President

  • Bio & Compensation - 
  • Eilleen M. Clavere
    Secretary
  • Cecilia H. Herbert
    Independent Trustee
  • Charles A. Hurty
    Independent Trustee














IBB ETF - Frequently Asked Questions

How have IBB shares performed in 2024?

iShares Biotechnology ETF's stock was trading at $135.85 at the beginning of 2024. Since then, IBB shares have increased by 2.9% and is now trading at $139.81.
View the best growth stocks for 2024 here
.

How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?

iShares Biotechnology ETF announced a quarterly dividend on Tuesday, December 19th. Shareholders of record on Thursday, December 21st will be paid a dividend of $0.124 per share on Wednesday, December 27th. This represents a $0.50 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Wednesday, December 20th.
Read our dividend analysis for IBB
.

What does IBB invest in?

iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.74 billion assets under management.

What stocks does iShares Biotechnology ETF hold?
What is the management fee for iShares Biotechnology ETF?

iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%.

When did iShares Biotechnology ETF's stock split?

iShares Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

Who are iShares Biotechnology ETF's major shareholders?

iShares Biotechnology ETF's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Citadel Advisors LLC (0.00%), Commerce Bank (1.31%), Wells Fargo & Company MN (1.20%), International Assets Investment Management LLC (1.01%), Barclays PLC (0.00%) and PNC Financial Services Group Inc. (0.70%).

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IBB) was last updated on 3/3/2024 by MarketBeat.com Staff